// App-Quantinova.ai

POS1292 (2021) : REAL-WORLD EFFECTIVENESS OF ETANERCEPT AND ADALIMUMAB IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) WITHOUT UVEITIS

Researchers

Presenter

  • L. Kearsley-Fleet

Principal Investigators

  • E. Baildam

  • M. Beresford

  • H. Foster

  • T. Southwood

  • W. Thomson

  • K. Hyrich

Medical Centers

  • University of Manchester, Manchester Academic Health Centre, Centre for Epidemiology Versus Arthritis, Manchester, United Kingdom

  • Alder Hey Children’s NHS Foundation Trust, Clinical Academic Department of Paediatric Rheumatology, Liverpool, United Kingdom

  • University of Liverpool, Institute of Life Course and Medical Sciences, Liverpool, United Kingdom

  • Newcastle University, Population Health Sciences Institute, Newcastle Upon Tyne, United Kingdom

  • Great North Childrens Hospital, Paediatric Respiratory Medicine, Newcastle upon Tyne, United Kingdom

  • University of Birmingham and Birmingham Children’s Hospital, Institute of Child Health, Birmingham, United Kingdom

  • Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, National Institute of Health Research Manchester Biomedical Research Centre, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Ophthalmology (OP)

Disease

  • Rheumatoid arthritis

  • Uveitis

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved